Articles

PRELIMINARY DATA ON AN ANTIBODY FOR AN ISOXANTHOHUMOL ELISA

Article number
848_26
Pages
247 – 252
Language
English
Abstract
Isoxanthohumol is a weak estrogenic prenylflavanone from hop that possesses anti-carcinogenic effects.
It is also a precursor of 8-Prenylnaringenin.
A carboxylic acid hapten of prenylflavanone was synthesized with a spacer arm of 2 carbons at the C4’ position.
The hapten was characterized by 1H-NMR, 13C-NMR, IR, MS (ESI+) and HR-MS (ESI+). It was coupled to Bovine Serum Albumin (BSA) by the activated ester method.
The coupling efficiency was assessed by MALDI-MS. It was found that the average coupling ratio was 26.5±1. Two antibodies were raised in two rabbits.
For the preliminary tests, competitive ELISA was chosen as the testing method.
To undertake such tests, H-prenylflavanone was coupled to swine thyroglobulin with a 50:1 ratio in order to perform the coating step.
Antibodies were tested for titres and the best was retained for further investigations.
A first standard curve was obtained with the following conditions: coating 0.03 μg/ml, Ac1: 1/250,000; Ac2: 1/10,000. Specificity tests were undertaken using various flavones and flavanones.
Cross-reactions were: Xanthohumol: 0.09%, 8-Prenylnaringenin: 2.71%, Naringenin: 12.6%, Liquiritigenin: 3.2%, Eriodictyol 1.6%. A sample of Lifenol® was assayed after extraction with ethanol:water 75:25 or enzyme hydrolysis and extraction with ethyl-acetate.
The average concentration was 6.3±2.0% or 6.0±2.1% after one or the other extraction.

Publication
Authors
S. Shinkaruk, V. Lamothe, C. Bennetau-Pelissero, B. Bennetau, P. Babin, J.-M. Schmitter
Keywords
isoxanthohumol, Hapten, ELISA, specificity test
Full text
Online Articles (33)
J. Matoušek | T. Kocábek | J. Škopek | L. Orctová | J. Stehlík | Z. Füssy | J. Patzak | K. Krofta | L. Maloukh | I. Roldán-Ruiz | A. Heyerick | D. De Keukeleire
E. Seigner | A. Lutz | K. Oberhollenzer | R. Seidenberger | S. Seefelder | F. Felsenstein
S. Whittock | G. Leggett | J. Jakše | B. Javornik | J. Carling | A. Kilian | P.D. Matthews | G. Probasco | J.A. Henning | P. Darby | A. Čerenak | A. Koutoulis
B. Javornik | L. Berke | Z. Luthar | J. Jakše | A. Čerenak | J.-M. Jeltsch | A. Forster | V. Phalip
L. Maloukh | J. De Keukeleire | J. Matoušek | P.D. Matthews | A. Schwekendiek | A. Heyerick | D. De Keukeleire | E. Van Bockstaele | I. Roldán-Ruiz
A. Čerenak | J. Jakše | Z. Luthar | B. Javornik | Z. Satovic | K. Carovic-Stanko
V. Phalip | A. Forster | R. Carapito | O. Habrylo | J.-M. Jeltsch | D. Hatsch
E.L. Peredo | R. Folgado | M.A. Revilla | R. Arroyo-García
A.H. Tadevosyan | S.KH. Mairapetyan | J.S. Alexanyan | H.M. Galstyan | R.J. Buniatyan | B.T. Stepanyan
K.E. Hummer | D.H. Gent | J.A. Henning | W.F. Mahaffee | C.M. Ocamb
J. Strathmann | E. Bertl | R. Hussong | K. Klimo | R. Steinle | N. Frank | C. Gerhauser
S. Bolca | S. Possemiers | W. Verstraete | T. Van de Wiele | A. Heyerick | D. De Keukeleire | I. Huybrechts | S. De Henauw | H. Depypere | M. Bracke
S. Shinkaruk | V. Lamothe | C. Bennetau-Pelissero | B. Bennetau | P. Babin | J.-M. Schmitter
M.H. Malakyan | S.A. Bajinyan | L.A. Vardevanyan | D.E. Yeghiazaryan | S.KH. Mairapetyan | A.H. Tadevosyan
E. Sikorska | T. Górecki | I. Khmelinskii | M. Sikorski
E.J. Buck | C. Wiedow | C. Carlisle | D. Chagné | R. Beatson